估值與業績共振 保險股集體走強
格隆匯10月19日丨近日持續走強的保險股今日漲勢繼續,A股中國人壽漲3.55%領漲,新華保險、中國太保漲超2%,中國平安、中國人保和西水股份均漲超1%;港股內銀股中,中國太保漲超3%領漲。“保險業利潤降幅繼續收窄,行業提前步入開門紅。”申萬宏源證券在保險行業三季報前瞻中提出,資產端改善+開門紅預期帶動保險板塊資產負債共振。隨着對宏觀預期的逐步修復和權益市場逐步回暖,上市險企淨利潤和價值增長有望實現逐季修復和改善,估值與業績的共振可期。光大證券也表示,預計四季度保險業進一步回暖,壽險保費收入分化趨勢繼續,部分經營情況下降的險企可能會戰略放棄四季度,主推2021年“開內紅”產品,這些公司四季度保費可能會小幅波動。預計四季度十年期國債到期收益率將保持較高水平,若進一步上升則保險公司投資收益有望進一步提升。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.